{
    "eid": "2-s2.0-85133106318",
    "title": "Immune Response after 2 Doses of BNT162b2 mRNA COVID-19 Vaccinations in Children and Adolescents with Cancer and Hematologic Diseases",
    "cover-date": "2022-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Epidemiology",
            "@code": "2713",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Bnt162b2 mrna covid-19 vaccine",
        "Covid-19 vaccine",
        "Neutralizing antibody",
        "Sars-cov-2 vaccine"
    ],
    "authors": [
        "Hansamon Poparn",
        "Chonlatis Srichumpuang",
        "Darintr Sosothikul",
        "Watsamon Jantarabenjakul",
        "Supanun Lauhasurayotin",
        "Piti Techavichit",
        "Kanhatai Chiengthong",
        "Yong Poovorapan"
    ],
    "citedby-count": 7,
    "ref-count": 22,
    "ref-list": [
        "Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants",
        "Suboptimal response to Coronavirus disease 2019 messenger RNA vaccines in patients with hematologic malignancies: a need for vigilance in the postmasking Era",
        "COVID-19 in pediatric oncology from French pediatric oncology and hematology centers: high risk of severe forms",
        "Effectiveness of Covid-19 vaccines against the B.1.617.2 (delta) variant",
        "COVID-19 in children with cancer in New York city",
        "SARS-CoV2-RNA persistence in naso-pharyngeal swabs",
        "COVID-19 infection in children and adolescents with cancer in Madrid",
        "Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19",
        "Dynamic re-immunization of off-treatment childhood cancer survivors: An implementation feasibility study",
        "Clinical and immunological effects of mRNA vaccines in malignant diseases",
        "Influenza and pneumococcal vaccination in hematological malignancies: a systematic review of efficacy, effectiveness, and safety",
        "Antibody status and incidence of SARS-CoV-2 infection in health care workers",
        "Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies",
        "Neutralization of SARS-COV-2 omicron pseudovirus by BNT162B2 vaccine-elicited human Sera",
        "Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial",
        "Efficacy of accelerated hepatitis B vaccination program in patients being actively treated for hematologic malignancies",
        "Plasma neutralization of the SARS-COV-2 omicron variant",
        "Revaccination of children after completion of standard chemotherapy for acute leukemia",
        "A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction",
        "Seroconversion rates following COVID-19 vaccination among patients with cancer",
        "COVID-19 reinfections: a rapid systematic review of case reports and case series",
        "China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China, 2019"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60002620",
        "affilname": "Faculty of Medicine, Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Chulalongkorn University"
    ]
}